Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells

Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells

Bibliographic Details
Main Authors:	Yun Xu, Masoud Nasri, Benjamin Dannenmann, Perihan Mir, Azadeh Zahabi, Karl Welte, Tatsuya Morishima, Julia Skokowa
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Series:	Stem Cell Research & Therapy
Online Access:	https://doi.org/10.1186/s13287-023-03511-4

Similar Items

NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
by: Yun Xu, et al.
Published: (2021-02-01)

Generation, expansion, and drug treatment of hematopoietic progenitor cells derived from human iPSCs
by: Benjamin Dannenmann, et al.
Published: (2022-06-01)

P458: HIPSC DISEASE MODELING TO STUDY LEUKEMIA DEVELOPMENT IN HAX1 VS ELANE ASSOCIATED CONGENITAL NEUTROPENIA
by: Benjamin Dannenmann, et al.
Published: (2023-08-01)

NAMPT-mediated NAD+ biosynthesis is indispensable for adipose tissue plasticity and development of obesity
by: Karen Nørgaard Nielsen, et al.
Published: (2018-05-01)

P1357: MILESTONE (MODIFYING ELANE GOLDBERG–HOGNES BOX TO INHIBIT EXPRESSION), A UNIVERSAL, SAFE AND EFFECTIVE CRISPR/CAS9N-MEDIATED GENOME EDITING STRATEGY FOR ELANE RELATED SEVERE CONGENITAL NEUTROPENIA
by: Masoud Nasri, et al.
Published: (2023-08-01)

Resveratrol differentially regulates NAMPT and SIRT1 in Hepatocarcinoma cells and primary human hepatocytes.
by: Susanne Schuster, et al.
Published: (2014-01-01)

Metabolic Regulators Nampt and Sirt6 Serially Participate in the Macrophage Interferon Antiviral Cascade
by: Widad Dantoft, et al.
Published: (2019-03-01)

Expression of n-MYC, NAMPT and SIRT1 in Basal Cell Carcinomas and their Cells of Origin
by: Lydia Brandl, et al.
Published: (2018-09-01)

P751: UNRAVELING THE DIFFERENT PATHOMECHANISMS OF CONGENITAL AND CYCLIC NEUTROPENIAS: CYCLIC EXPRESSION OF HEMATOPOIETIC STEM-CELL-SPECIFIC TRANSCRIPTION FACTORS IN CYCLIC NEUTROPENIA
by: Karl Alexander Zeidler, et al.
Published: (2023-08-01)

Beyond iPS!
by: Editorial
Published: (2012-01-01)

Linkage of NAMPT promoter variants to eNAMPT secretion, plasma eNAMPT levels, and ARDS severity
by: Heather Lynn, et al.
Published: (2023-07-01)

Replicative Senescence in Human Fibroblasts Is Delayed by Hydrogen Sulfide in a NAMPT/SIRT1 Dependent Manner.
by: Reiko Sanokawa-Akakura, et al.
Published: (2016-01-01)

Role of Nampt-Sirt6 Axis in Renal Proximal Tubules in Extracellular Matrix Deposition in Diabetic Nephropathy
by: Hirokazu Muraoka, et al.
Published: (2019-04-01)

Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
by: Heuy-Ching Wang, et al.
Published: (2014-01-01)

Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
by: Heuy-Ching Wang, et al.
Published: (2014-10-01)

NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner
by: Bi-He Cai, et al.
Published: (2022-03-01)

iPS Cells—The Triumphs and Tribulations
by: Riddhi Sharma
Published: (2016-06-01)

Evolving science enhanced with iPS
by: Editor
Published: (2007-11-01)

P.S. to operating systems /
by: 378853 Dowdy, Larry, et al.
Published: (1993)

Alternative pathway of bile acid biosynthesis contributes to ameliorate NASH after induction of NAMPT/NAD+/SIRT1 axis
by: Na Yang, et al.
Published: (2023-08-01)

Indispensable role of Galectin-3 in promoting quiescence of hematopoietic stem cells
by: Weizhen Jia, et al.
Published: (2021-04-01)

iPS-Cinderella Story in Cell Biology
by: Editorial
Published: (2010-01-01)

Modeling Kidney Disease with iPS Cells
by: Benjamin S. Freedman
Published: (2015-12-01)

Modeling Kidney Disease with iPS Cells
by: Benjamin S. Freedman
Published: (2015-01-01)

Establishment of LIF-dependent human iPS cells closely related to basic FGF-dependent authentic iPS cells.
by: Hiroyuki Hirai, et al.
Published: (2012-01-01)

Wnt/ß-catenin-mediated p53 suppression is indispensable for osteogenesis of mesenchymal progenitor cells
by: Xin Zhou, et al.
Published: (2021-05-01)

TRAF3IP2 drives mesenchymal stem cell senescence via regulation of NAMPT-mediated NAD biosynthesis
by: Xiaoran Huang, et al.
Published: (2023-09-01)

SIRT7 and p53 interaction in embryonic development and tumorigenesis
by: Berta N. Vazquez, et al.
Published: (2024-01-01)

Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells
by: Yusuke Azami, et al.
Published: (2021-03-01)

The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
by: Fuga Takahashi, et al.
Published: (2023-02-01)

Overview: an iPS cell stock at CiRA
by: Masafumi Umekage, et al.
Published: (2019-09-01)

Hepatic Differentiation of Mouse iPS Cells in Vitro
by: Masaya Iwamuro M.D., et al.
Published: (2010-06-01)

iPS cells generation: an overview of techniques and methods
by: Telpalo-Carpio SA, et al.
Published: (2013-04-01)

Modulation of pluripotency in the porcine embryo and iPS cells.
by: Aida Rodríguez, et al.
Published: (2012-01-01)

Activation of the JNKs/ATM-p53 axis is indispensable for the cytoprotection of dermal fibroblasts exposed to UVB radiation
by: Eleni Mavrogonatou, et al.
Published: (2022-07-01)

Expression and regulation of nampt in human islets.
by: Karen Kover, et al.
Published: (2013-01-01)

Chemistry-led investigations into the mode of action of NAMPT activators, resulting in the discovery of non-pyridyl class NAMPT activators
by: Siyuan Tang, et al.
Published: (2023-02-01)

Association of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population
by: Qingyu Dou, et al.
Published: (2015-09-01)

Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
by: Yang Bijie, et al.
Published: (2023-08-01)

Severe congenital neutropenia: pathophysiology of leukemogenic transformation
by: J. Skokowa, et al.
Published: (2022-11-01)